↓ Skip to main content

Discussion about Several Potential Drawbacks of PEGylated Therapeutic Proteins

Overview of attention for article published in Biological and Pharmaceutical Bulletin, December 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
3 X users
patent
3 patents

Citations

dimensions_citation
114 Dimensions

Readers on

mendeley
175 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Discussion about Several Potential Drawbacks of PEGylated Therapeutic Proteins
Published in
Biological and Pharmaceutical Bulletin, December 2013
DOI 10.1248/bpb.b13-00661
Pubmed ID
Authors

Fan Zhang, Mu-rong Liu, Hai-tong Wan

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 175 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Russia 2 1%
Unknown 173 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 15%
Student > Ph. D. Student 24 14%
Student > Bachelor 23 13%
Researcher 19 11%
Other 8 5%
Other 21 12%
Unknown 54 31%
Readers by discipline Count As %
Chemistry 32 18%
Pharmacology, Toxicology and Pharmaceutical Science 22 13%
Biochemistry, Genetics and Molecular Biology 20 11%
Agricultural and Biological Sciences 14 8%
Medicine and Dentistry 11 6%
Other 17 10%
Unknown 59 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2023.
All research outputs
#4,820,057
of 25,922,020 outputs
Outputs from Biological and Pharmaceutical Bulletin
#308
of 3,302 outputs
Outputs of similar age
#51,714
of 322,624 outputs
Outputs of similar age from Biological and Pharmaceutical Bulletin
#6
of 80 outputs
Altmetric has tracked 25,922,020 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,302 research outputs from this source. They receive a mean Attention Score of 4.2. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 322,624 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.